About Virmedex
Virmedex is a company based in Barcelona (Spain) founded in 2022 by Dani Tost, Ariel Von Barnekow, and Nuria Bonet Codina.. Virmedex has raised $162.15 thousand across 1 funding round from investors including Grow Venture Partners. Virmedex offers products and services including virCPB, virECMO, and Dex. Virmedex operates in a competitive market with competitors including Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Proximie, among others.
- Headquarter Barcelona, Spain
- Founders Dani Tost, Ariel Von Barnekow, Nuria Bonet Codina
-
Sectors
EducationHealthcare Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$162.15 K (USD)
in 1 rounds
-
Latest Funding Round
$162.15 K (USD), Seed
Feb 22, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virmedex
Virmedex offers a comprehensive portfolio of products and services, including virCPB, virECMO, and Dex. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Video game for cardiopulmonary bypass training and surgical decision-making.
Immersive game simulating ECMO processes for healthcare skill development.
Chatbot providing real-time support for ECMO and perfusion training.
Funding Insights of Virmedex
Virmedex has successfully raised a total of $162.15K through 1 strategic funding round. The most recent funding activity was a Seed round of $162.15 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $162,148
-
First Round
First Round
(22 Feb 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Seed - Virmedex | Valuation | Grow Venture Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Virmedex
Virmedex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Grow Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grow Venture Partners is focused on investing in deep tech spin-offs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Virmedex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Virmedex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Virmedex Comparisons
Competitors of Virmedex
Virmedex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Proximie, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based surgical simulation is enabled via VR and haptics.
|
|
| domain | founded_year | HQ Location |
VR-based medical training systems are developed for patient care simulations.
|
|
| domain | founded_year | HQ Location |
Virtual reality platform for surgical training is provided.
|
|
| domain | founded_year | HQ Location |
Provider of a VR-based medical simulation training platform
|
|
| domain | founded_year | HQ Location |
Provider of a cloud-based VR platform for surgery guidance
|
|
| domain | founded_year | HQ Location |
VR-based learning devices for surgeons are provided by apoQlar.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Virmedex
When was Virmedex founded?
Virmedex was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is Virmedex located?
Virmedex is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of Virmedex?
Dani Tost is the current CEO of Virmedex. They have also founded this company.
Is Virmedex a funded company?
Virmedex is a funded company, having raised a total of $162.15K across 1 funding round to date. The company's 1st funding round was a Seed of $162.15K, raised on Feb 22, 2024.
What does Virmedex do?
Provider of AR-VR-based training for healthcare professionals. It develops gamified software for specialized training in the medical field. It provides virCPB a platform for cardiopulmonary bypass training designed as a video game.
Who are the top competitors of Virmedex?
Virmedex's top competitors include Fundamental Surgery, SimX and Proximie.
What products or services does Virmedex offer?
Virmedex offers virCPB, virECMO, and Dex.
Who are Virmedex's investors?
Virmedex has 1 investor. Key investors include Grow Venture Partners.